Navigation Links
Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
Date:6/2/2008

OR AKIVA, Israel, June 2 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd. (TASE: ITGI) announced today the first commercial use of the CE certified Over and Under(R) Pericardium Covered Stent (PCS) in the UK

Over and Under(R) is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations such as degenerated Saphenous Vein Graft (SVG), aneurysms and perforations.

The first Over and Under(R) PCS commercial implantation and first implantation in the UK was performed at the Royal Bournemouth Hospital whose Percutaneous Coronary Intervention Leader is Dr. Suneel Talwar and the procedure was performed by the Cath Lab director Dr. Rosie Swallow. The medical team granted the procedure as a success due to the special characteristics of the stent and the ease at which the stent was delivered to the lesion.

A pilot study designed to compare the deliverability of a PTFE covered stent vs. Over and Under(R) PCS was presented by Dr. Haim Danenberg, Head of Interventional Cardiology Unit and the company's medical director, at the annual EuroPCR meeting. Study was performed in phantom and porcine coronaries. Over and Under(R) PCS appeared to be significantly superior in deliverability in both model systems.

At its initial step, ITGI launched Over and Under(R) PCS in England, in collaboration with Pyramed, the UK distributor. "We are very pleased with Pyramed's marketing. They have recently purchased the stents and already managed to initiate its use," commented Efri Argaman, CEO of ITGI Medical, "The medical team's satisfaction strengthens our belief that Over and Under(R) PCS ushers in a new era for interventional medicine."

About Over and Under(R)

Over and Under(R) is a unique stent, first in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen. Over and Under(R) PCS is indic
'/>"/>

SOURCE ITGI Medical LTD
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
2. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
3. National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
6. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
7. PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
8. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
9. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
10. Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
11. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
(Date:11/5/2009)...EGO, CA, November 5, 2009 /PRNewswire-FirstCall/ -...d on using proprietary taste receptor-based techno...e food, beverage, and ingredient supply industries...inancial results for the third quarter ended Septe... third quarter of 2009, compared to $4.0 million f...
(Date:11/5/2009)... Drug safety specialty firm BioSoteri...nd Informatics earned the Certified Professional i...l from the American Society for Training and Devel...lewell has more than fifteen years of medical comm... is responsible for the development of the company...
(Date:11/4/2009)... The Human Anthrax Vaccine Program mu...eted the feature film "A Call to Arms:2009 Ed...y "Fatal Immunity: The Human Anthrax Vaccine ...nd present danger of top secret government science...h no accountability to its victims. It is availab...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
... Md., Oct. 24 MedImmune, Inc. announced,today tha...unty (CVC-MC),has recognized the company for its e... MedImmune received the CVC-MC,s 2007 Corporate Vo...n,s leading biotechnology company, MedImmune is pr...hose employees strive to give,back to the communit...
...,000 Additional Votes "FOR" Required for Integra M...c.,(NASDAQ: ISOT ) ("IsoTis"), an orthobiologics ... special meeting of stockholders again, to October...Integra LifeSciences Holdings,Corporation (NASDAQ:...plan of,merger dated as of August 6, 2007. The sp...
...la., Oct. 24 Nabi,Biopharmaceuticals (Nasdaq: NA...er 18, 2007, it commenced mailing its definitive p... proposed sale of its biologics strategic,business... to Biotest,Pharmaceuticals Corporation, a wholly ...t purchase agreement dated as of September 11, 200...
Other Biology Technology:IsoTis Adjourns Special Meeting to October 26, 2007 2IsoTis Adjourns Special Meeting to October 26, 2007 3IsoTis Adjourns Special Meeting to October 26, 2007 4Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results 2Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results 3
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
(Date:11/4/2009)...f., Nov. 4 GenVault Corporation (C....D., Ph.D., has joined its Board of Directors. Dr...e Salk Institute, is an acclaimed physician-scient...alk Institute, Dr. Brody served as president of Th... National Academy of Engineering and the Institute...
(Date:11/3/2009)...L (November 4, 2009) For more than 25 years, all ...( Strombus gigas ) have been unsuccessfuluntil now...g techniques to produce beaded (nucleated) and non...been developed by scientists from Florida Atlantic...e (HBOI). With less than two years of research and...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 1Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 3The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 1The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 2The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 3
... dwelling in ocean-bottom sediments appears in lab...ant multiple myeloma cells, and potentially with l...Farber Cancer Institute researchers in the Novembe...d, NPI-0052, has been found to block or inhibit ca...The proteasome work as a cell,s "garbage disposal,...
...s system must coordinate a laundry list of signals...y level, food preferences, and metabolic need, whi...ality of available food, determined by its smell a...phila have traced the path of olfactory signals be...h set off neurons that signal the antennal lobe of...
...air birth defectsResearchers at Children,s Hospita...truct defective tracheas (windpipes) in fetal lamb...ow sections of cartilage tube, and then implanting... the womb. , The tracheal repair technique is one ... at Children,s that use the fetus,s own cells, dra...
Other Biology News:Compound from marine bacteria shows potential as multiple myeloma therapy 2Compound from marine bacteria shows potential as multiple myeloma therapy 3How Fruitflies Know It's Time for Lunch 2How Fruitflies Know It's Time for Lunch 3Cells from amniotic fluid used to tissue-engineer a new trachea 2Cells from amniotic fluid used to tissue-engineer a new trachea 3
Stackable Refrigerated Shaker, 230V, 50 Hz from Thermo Scientific
18" 18" Dedicated Platform with (8) 1l Clips from Thermo Scientific
29.5" 18" Dedicated Platform with (61) 125ml Clips, for Stackable Shakers from Thermo Scientific
PCR Workstation from Thermo Scientific
Biology Products: